n,n-dimethylarginine has been researched along with Osteoarthritis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bekpinar, S; Erdogan, N; Karaarslan, F; Karagulle, MZ; Ozkuk, K; Seringec Karabulut, S | 1 |
Briggs, WTE; Castro, C; FitzGerald, GA; Griffin, JL; Karlson, EW; Lahens, NF; Li, X; Malik, D; Meng, H; Rhoades, SD; Ricciotti, E; Sparks, JA; Tang, SY; Weljie, AM; West, JA | 1 |
1 trial(s) available for n,n-dimethylarginine and Osteoarthritis
Article | Year |
---|---|
How does spa treatment affect cardiovascular function and vascular endothelium in patients with generalized osteoarthritis? A pilot study through plasma asymmetric di-methyl arginine (ADMA) and L-arginine/ADMA ratio.
Topics: Aged; Arginine; Balneology; Blood Pressure; Endothelium, Vascular; Female; Heart Rate; Humans; Male; Middle Aged; Osteoarthritis; Pilot Projects | 2018 |
1 other study(ies) available for n,n-dimethylarginine and Osteoarthritis
Article | Year |
---|---|
Cyclooxygenase-2, Asymmetric Dimethylarginine, and the Cardiovascular Hazard From Nonsteroidal Anti-Inflammatory Drugs.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arginine; Blood Pressure; Blood Urea Nitrogen; Cardiovascular Diseases; Celecoxib; Creatinine; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Humans; Kidney; Metabolome; Mice; Mice, Inbred C57BL; Mice, Knockout; Osteoarthritis; Placebo Effect | 2018 |